MLH CCOP is now an NCORP

Submitted by Diana Blade, Administrator, Cancer Clinical Trials.

 

The MLH Community Clinical Oncology Program (CCOP) is now officially a National Cancer Institute Community Oncology Research Program (NCORP) and is available at Lankenau Medical Center and Bryn Mawr, Paoli and Riddle Hospitals. NCORP is similar to CCOP, where National Cancer Institute-sponsored trials are conducted. The trials focus on cancer prevention, cancer control, screening and post-treatment management for a variety of different cancers. A new component of NCORP is cancer care delivery research (CCDR) which focuses on health outcomes, health costs, and disparities in care in relation to oncology patients. Main Line Health NCORP is one of 34 Community Sites in the country.

 

MLH NCORP Principal Investigator (PI) is Albert DeNittis, MD, located at LMC; Associate NCORP PI is John Devlin, MD, located at BMH, Michael Dabrow, DO, is the Site PI for Paoli Hospital and Rashmi Sanjay, MD, is the site PI at Riddle Hospital.

 

Having the NCORP available at all four acute care hospitals in the system expands the access our patients have to innovative treatment care options and highlights another way we strive to provide a superior patient experience to each Main Line Health patient.

 

For more information, contact me at 484.476.2649. For a listing of current MLH clinical trials, click here.

 

This entry was posted in Clinician News and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published.